324623 Sigma-AldrichEg5 Inhibitor IV, VS-83 - CAS 909250-29-9 - Calbiochem
The Eg5 Inhibitor IV, VS-83, also referenced under CAS 909250-29-9, controls the biological activity of Eg5. This small molecule/inhibitor is primarily used for Cell Structure applications.
More>> The Eg5 Inhibitor IV, VS-83, also referenced under CAS 909250-29-9, controls the biological activity of Eg5. This small molecule/inhibitor is primarily used for Cell Structure applications. Less<<Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.
Sinónimos: 5-Fluoro-3,4-dihydro-4(3ʹ-hydroxyphenyl)quinazoline-2(1H)-thione
Productos recomendados
Descripción
| Replacement Information |
|---|
Tabla espec. clave
| CAS # | Empirical Formula |
|---|---|
| 909250-29-9 | C₁₄H₁₁FN₂OS |
Precios y disponibilidad
| Número de referencia | Disponiblidad | Embalaje | Cant./Env. | Precio | Cantidad | |
|---|---|---|---|---|---|---|
| 324623-5MG |
|
Frasco de vidrio | 5 mg |
|
— |
| Description | |
|---|---|
| Overview | A cell-permeable Monastrol (Cat. No. 475879) analog with much enhanced potency and selectivity (over 8 other kinesins) in inhibiting mitotic kinesin Eg5-ATPase activity (IC50 = 1.17 vs. 20.73 µM for VS-83 and Monastrol, respectively) and in inducing monoasters formation (EC50 = 7.27 vs. 58.74 µM for BSC-1 cells treated with VS-83 and Monastrol, respectively). Shown to exhibit ≥10-fold antiproliferative activity than Monastrol against U-87 MG, U-118 MG, and U-373 MG glioblastoma cells. |
| Catalogue Number | 324623 |
| Brand Family | Calbiochem® |
| Synonyms | 5-Fluoro-3,4-dihydro-4(3ʹ-hydroxyphenyl)quinazoline-2(1H)-thione |
| References | |
|---|---|
| References | Muller, C., et al. 2007. Cancer Chemother. Pharmacol. 59, 157. Santamaria, A., et al. 2007. Mol. Biol. Cell 18, 4024. Sarli, V., et al. 2005. ChemBioChem 6, 2005. |
| Product Information | |
|---|---|
| CAS number | 909250-29-9 |
| Form | White solid |
| Hill Formula | C₁₄H₁₁FN₂OS |
| Chemical formula | C₁₄H₁₁FN₂OS |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Purity | ≥99% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Número de referencia | GTIN |
| 324623-5MG | 04055977197389 |
Documentation
Licencias necesarias
| Título |
|---|
| CARTA DE USO GENERAL 2016 |
| PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD |
Eg5 Inhibitor IV, VS-83 - CAS 909250-29-9 - Calbiochem Ficha datos de seguridad (MSDS)
| Título |
|---|
Referencias bibliográficas
| Visión general referencias |
|---|
| Muller, C., et al. 2007. Cancer Chemother. Pharmacol. 59, 157. Santamaria, A., et al. 2007. Mol. Biol. Cell 18, 4024. Sarli, V., et al. 2005. ChemBioChem 6, 2005. |
| Ficha técnica | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.
|